Page last updated: 2024-11-05

4-fluorophenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-Fluorophenol, also known as p-fluorophenol, is a colorless to light yellow solid with a pungent odor. It is a versatile aromatic compound used as an intermediate in the synthesis of various pharmaceuticals, agrochemicals, and other organic compounds. 4-Fluorophenol is commonly synthesized through the fluorination of phenol using various reagents like HF, SF4, or fluorinating agents. It exhibits antimicrobial and antifungal properties, showing potential applications in the pharmaceutical industry. Research into 4-Fluorophenol focuses on its reactivity, its use as a building block in organic synthesis, and its potential applications in materials science and environmental chemistry. Its relatively high reactivity and unique properties make it a valuable tool for developing new and innovative chemical processes and products.'

4-fluorophenol: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4-fluorophenol : A fluorophenol that is phenol in which the hydrogen para- to the hydroxy group has been replaced by a fluorine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9732
CHEBI ID42533
SCHEMBL ID78213
MeSH IDM0278318

Synonyms (49)

Synonym
einecs 206-736-0
nsc 10295
brn 1362752
ccris 665
4-fluorophenol
phenol, 4-fluoro-
371-41-5
nsc10295
p-fluorophenol
phenol, p-fluoro-
nsc-10295
FPN ,
4-fluorophenol, 99%
4-fluoranylphenol
F0160
AKOS000119023
4-fluoro-phenol
A823540
para-fluorophenol
4-06-00-00773 (beilstein handbook reference)
ec 206-736-0
unii-k6dt6tr5e5
k6dt6tr5e5 ,
FT-0618549
AM20040308
SCHEMBL78213
4-flourophenol
4-flurophenol
4fluorophenol
4fluoro phenol
p-fluoro phenol
p-fluoro-phenol
4-fluoro phenol
DTXSID0052047
W-200550
1219804-93-9
PS-9253
mfcd00002316
CS-W008731
F0001-1065
CHEBI:42533
Q27460393
phenol, 4-fluoro-; phenol, p-fluoro- (6ci,8ci); 4-fluorophenol; 4-hydroxyphenyl fluoride; nsc 10295; p-fluorophenol
EN300-19431
STL183322
CCG-302492
4-fluorophenol-d5
fluorophenol, 4-
4-hydroxyphenyl fluoride
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
fluorophenolA halophenol that is any phenol containing one or more covalently bonded fluorine atoms.
monofluorobenzenesAny member of the class of fluorobenzenes containing a mono- or poly-substituted benzene ring carrying a single fluorine substitutent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID23714Partition coefficient (logP)1988Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.
AID1134603Oleyl alcohol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID282833Activity against caspase-mediated apoptosis in mouse L1210 cells at 0.1 mM2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
AID303044Cytotoxicity against human MIA PaCa2 cells after 72 hrs by MTT assay2007Journal of medicinal chemistry, Nov-15, Volume: 50, Issue:23
Synthesis and evaluation of 3-aryloxymethyl-1,2-dimethylindole-4,7-diones as mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1) activity.
AID203473Binding constant against bovine serum albumin1988Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.
AID282835Cytotoxicity against mouse L1210 cells2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID303043Cytotoxicity against human MIA PaCa2 cells after 4 hrs by MTT assay2007Journal of medicinal chemistry, Nov-15, Volume: 50, Issue:23
Synthesis and evaluation of 3-aryloxymethyl-1,2-dimethylindole-4,7-diones as mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1) activity.
AID1134600Octanol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID23978Capacity ratio (log k'w)1988Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.
AID342464Dissociation constant, pKa of the compound2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
The many roles for fluorine in medicinal chemistry.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (6.67)18.7374
1990's2 (6.67)18.2507
2000's15 (50.00)29.6817
2010's11 (36.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.55 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index5.22 (4.65)
Search Engine Demand Index50.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]